Kriya Raises $320 million Series D
Kriya raised $320M in Series D financing. Kriya announced a funding event covered by Pharmaceutical Technology..
What it does
Kriya announced a funding event covered by Pharmaceutical Technology.. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.
Traction
Kriya secures $320m in Series D for gene therapy development - Pharmaceutical Technology. Source coverage says: Kriya secures $320m in Series D for gene therapy development - Pharmaceutical Technology.
Trend impact
This enrichment fell back to title-only parsing because Tavily returned no usable answer or source excerpts. The item still points to active funding demand in the covered segment. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.
Funding history
- September 11, 2025 · Series D · $320 million · undisclosed investors
Products & services
- Healthcare & Life Sciences workflow monitoring tied to the funding announcement
- Customer-facing product described on the company website
- Operational tooling for healthcare & life sciences teams
- Data capture and reporting across core business processes
- Team expansion support funded by the latest round